Circulating kidney injury molecule-1 is a novel diagnostic biomarker for renal dysfunction during long-term adefovir therapy in chronic hepatitis B

The aim of this study was to evaluate serum kidney injury molecule-1 (KIM-1) as a new diagnostic marker of renal dysfunction in chronic hepatitis B (CHB) patients receiving long-term adefovir dipivoxil (ADV) treatment. We retrospectively enrolled 85 patients treated with ADV and 85 patients treated...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Ziyue, Shen, Chuan, Wang, Yadong, Wang, Wei, Zhao, Qian, Liu, Zhenzhong, Wang, Yang, Zhao, Caiyan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2016
Materias:
4200
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5591140/
https://www.ncbi.nlm.nih.gov/pubmed/27858892
http://dx.doi.org/10.1097/MD.0000000000005264

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5591140/
https://www.ncbi.nlm.nih.gov/pubmed/27858892
http://dx.doi.org/10.1097/MD.0000000000005264

Ejemplares similares